35Pharma
Blood & Organ Banks · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
750 St Laurent Blvd Ste 101, Montreal, Q...Website
www.35pharma.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
3
3
3
4
2
About 35Pharma
35Pharma is a clinical-stage biopharmaceutical company dedicated to designing and developing innovative therapeutics targeting the TGF-beta superfamily, specifically focusing on Activin x GDF biology. Their lead candidate, HS235, is in clinical development for treating pulmonary hypertension, heart failure, and obesity, addressing significant unmet medical needs. The company leverages advanced protein engineering to create multi-specific ligand traps that are highly selective and potent, facilitating rapid clinical trials. With a team experienced in advancing complex biologics, 35Pharma aims to deliver transformative therapies to improve patient outcomes.Explore more
35Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is 35Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if 35Pharma has recently received funding, and reach out quickly before it becomes old news!
Check out if 35Pharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
35Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once 35Pharma has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when 35Pharma launches new products
Earning: See what the market has to say on 35Pharma recently announced quarterly report
Click to see if 35Pharma had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at 35Pharma
Recommended Actions
Reach out to Masked Content who joined 35Pharma as Masked Content
Find 3 more new buyers
Compare Similar Companies to 35Pharma
Compare insights from companies similar to 35Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
35Pharma is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
35Pharma is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about 35Pharma.
35Pharma financials insights
Gather financial insights about 35Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series C
$53M
35Pharma Tech Stack
A closer look at the technologies used by 35Pharma
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Open Position
Hiring Plans
35Pharma has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Technologies mentioned include: Cloudflare, and WordPress.com.
Hiring Plans
Hiring Plans
35Pharma is hiring in Medical & Health for the first time in 12 months.
Hiring Plans
Hiring Plans
Hiring Plans
35Pharma News & Media
GSK continues dealmaking spree with $950m 35Pharma acquisition
The 35Pharma acquisition comes as GSK looks to stock up its pipeline amid the looming patent expiries soon to impact its portfolio.35Pharma to be Acquired by GSK to Accelerate Development of - GlobeNewswire
Acquisition includes HS235, a potentially best-in-class activin signalling inhibitor in clinical development for treatment of cardiopulmonary diseasesHS235...35Pharma to be Acquired by GSK to Accelerate Development of HS235, a Potential Best-in-Class Investigational Medicine for Pulmonary Hypertension (PH)
MONTREAL, Feb. 25, 2026 (GLOBE NEWSWIRE) -- 35Pharma, a Canada-based, private, clinical-stage biopharmaceutical company specialised in the development of novel protein-based therapeutics today announced it has entered into an agreement with GSK plc (GSK), under which GSK will acquire all of the outstanding equity interests in 35Pharma. The acquisition includes HS235, a potential best-in-class investigational medicine that has completed phase I healthy volunteer clinical trials with studies to st
Read more news
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding 35Pharma
Sign Up For FreeTo access detailed company insights
35Pharma is a clinical-stage biopharmaceutical company dedicated to designing and developing innovative therapeutics targeting the TGF-beta superfamily, specifically focusing on Activin x GDF biology. Their lead candidate, HS235, is in clinical development for treating pulmonary hypertension, heart failure, and obesity, addressing significant unmet... Read More
